These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37718238)

  • 1. Potential effects of carbamylation on the prothrombin time, activated partial thromboplastin time, and fibrinogen.
    Mastella AK; de Carvalho JAM; Pereira KN; das Neves YS; Stein CS; Bochi GV; Moresco RN
    Int J Lab Hematol; 2024 Feb; 46(1):173-175. PubMed ID: 37718238
    [No Abstract]   [Full Text] [Related]  

  • 2. The activated partial thromboplastin time may not reveal even severe fibrinogen deficiency.
    Abildgaard A; Hvas AM
    Clin Chem Lab Med; 2021 Jun; 59(7):e297-e300. PubMed ID: 33544482
    [No Abstract]   [Full Text] [Related]  

  • 3. Preanalytical Variables on Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen.
    Joob B; Wiwanitkit V
    Clin Lab; 2016 Jul; 62(7):1379. PubMed ID: 28164643
    [No Abstract]   [Full Text] [Related]  

  • 4. [EVALUATION OF METHODS FOR THE DETERMINATION OF THE PROTHROMBIN COMPLEX ACTIVITY].
    MARES J; PODLIPNY J
    Z Arztl Fortbild (Jena); 1964 Jun; 58():709-13. PubMed ID: 14240434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100].
    Barbe D; Bauduer F; Tanguy A
    Ann Biol Clin (Paris); 1991; 49(10):507-13. PubMed ID: 1807170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation studies in patients with marked thrombocytopenia due to severe preeclampsia.
    Prieto JA; Mastrobattista JM; Blanco JD
    Am J Perinatol; 1995 May; 12(3):220-2. PubMed ID: 7612100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation quality control surveys in France.
    Goguel AF; Houbouyan LL; Roussi JH
    Scand J Haematol Suppl; 1980; 37():150-2. PubMed ID: 6941434
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood coagulation tests ].
    Fukue H; Fukutake K
    Rinsho Byori; 1997 Nov; Suppl():99-106. PubMed ID: 9508613
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of a centrifugal analyzer for a chromogenic prothrombin time, a chromogenic activated partial thromboplastin time and a kinetic fibrinogen assay in a routine hospital laboratory.
    de Metz M; van Wersch JW
    Haemostasis; 1987; 17(5):254-9. PubMed ID: 3666583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin times and clottable fibrinogen determination on an automated coagulation laboratory (ACL-810).
    Castillo JB; Farag AM; Mammen EF; Sachs RJ
    Thromb Res; 1989 Jul; 55(2):213-9. PubMed ID: 2781525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
    d'Audigier C; Delassasseigne C; Robert A; Eschwège V
    Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated clot-based methods in coagulation testing: current and future considerations.
    Walenga JM; Hoppensteadt D; Fareed J; Silberman S; Shelvin P
    Semin Thromb Hemost; 1983 Oct; 9(4):245-9. PubMed ID: 6658458
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring of haemostasis in liver transplantation: comparison of laboratory based and point of care tests.
    Herbstreit F; Winter EM; Peters J; Hartmann M
    Anaesthesia; 2010 Jan; 65(1):44-9. PubMed ID: 19889111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of intrapartum and postpartum bleeding based on changes in blood coagulation and fibrinolysis during pregnancy].
    Fuse Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):405-10. PubMed ID: 3494090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of the Quick prothrombin test; with reference to the statistical significance of variations in the prothrombin concentration with use of a stable thromboplastin of high potency.
    AGGELER PM; HOWARD J
    Blood; 1946 May; 1():220-33. PubMed ID: 21026403
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the automated coagulation analyzer SYSMEX CA 6000.
    Quehenberger P; Kapiotis S; Handler S; Ruzicka K; Speiser W
    Thromb Res; 1999 Oct; 96(1):65-71. PubMed ID: 10554086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma.
    Mischke R; Wolling H
    Haemostasis; 2000; 30(3):123-30. PubMed ID: 11014962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzer.
    Rose VL; Dermott SC; Murray BF; McIver MM; High KA; Oberhardt BJ
    Arch Pathol Lab Med; 1993 Jun; 117(6):611-7. PubMed ID: 8503733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE FIBROMETER SYSTEM FOR ROUTINE COAGULATION TESTS: PROTHROMBIN TIME AND PARTIAL THROMBOPLASTIN TIME, MACRO AND MICRO.
    MIALE JB
    Am J Clin Pathol; 1965 May; 43():475-80. PubMed ID: 14287798
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a coagulation analyzer.
    Serrano L; Oakley E; Clark K
    Am Clin Lab; 2000 Aug; 19(7):18-9. PubMed ID: 11317415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.